In the case of the filtrable fowl tumours which have been shown to be due to a virus, it is permissible to use the term " immunity ".
The earliest workers on experimental cancer observed the regression of tumours, and the subsequent resistance to further transplantation, and sought by experimentation to find the cause of the regression with the idea of clinical application. Probably no aspect of the cancer problem has received more consideration and prompted more experimiients. Woglom in 1929, in his review of the literature, discussed over 600 papers, most of which were published since 1913. Many important papers have appeared since 1929. Hence a comprehensive review of the literature is impossible.
Before 1903 workers in isolated laboratories had made observations on tumours in animals, especially in mice, and had transplanted fragments of the tumours into other mice, and thus carried the tumour strain, but it was not generally accepted that these scientific curiosities had a very close relation to the tumour problem in man.
In 1889 Hanau described the first successful transplantation of carcinoma within the same species, and two years later Morau (1891) reported a carcinoma which had been carried through seventeen generations of transplants, over a three-year period. Jensen, Loeb, and Borrel, made extensive observations on experimental tumour, and as early as 1901 Jensen reported the spontaneous regression of a tumour in a mouse.
With the establishment of the Imperial Cancer Research Fund, coordinated research on cancer was begun, and it is to the men that formed the original group and to their successors, that the world will always owe a deep debt of gratitude. They first established the fact that cancer is fuindamentally the same in all animals and in man. They studied many strains of transplantable tumours in many different species of animals, and their observations form the basis for much of the subsequent research on cancer.
In 1906 Bashford, Murray and Cramer reported their investigations into the natural and induced resistance of mice to the growth of cancer. They showed that animals in which tumours had developed and then had been absorbed were highly refractory to further inoculation. Animals in which a tumour had disappeared, following exposure to radium, were refractory in the same way and to a similar degree as those in which absorption had occurred spontaneously. They found fuirther that although protection was absolute for the tumour strain recovered from, it was not necessarily absolute for other tumours. They thus suggest a specificity in the protection.
Bashford, Murray and Haaland carried out extensive experiments on the induction of resistance to transplanted tumours by preliminary injection of normal tissue cells such as red blood-cells, mammary gland, skin and embryo, and found that by this procedure a varying degree of resistance to transplantation might be produced. These results were obtained only when living tissues of the same species were used throughout the experiment.
When a tumour transplantation is made into a susceptible animal, the peripheral parenchymal cells live, but the central cells and the stroma of the graft die. Russell studied the fate of grafts placed in resistant mice and found that for the first two days the changes were the same as those observed in normal mice, but that on the third and subsequent days there was a marked difference. The host fibroblasts did not penetrate the implanted fragment, there was no stroma formation, and in place of vascularization and growth there was a shrinkage of the necrotic centre and a cleft formed between the cells of the tumour and the host. The thin peripheral layer of tumour cells thus formed a cystic cavity which persisted for some days, acnd was not completely absorbed until from twelve to fourteen days had elapsed. Woglom, ulsing Flexner-Jobling rat adenocarcinoma, confirmed these findings.
Russell then carried out his important experiments on c concomnitailt induced immunity ". Various strains of tumour were transplanted into mice (in one flank) and, after about tw-o weeks' growth, were surgically removed. Two or three days later the same, or different, strains of tumour were transplanted into these micein the opposite flank. Russell found that the growth of some strains, notably 63, did not confer noticeable resistance to subsequent transplantation, while the growth of other strains, notably 206, would render mice highly resistant not only to 206, but also to many other strains, including 63. He thus showed that certain strains of tumours by their growth in an animal, confer resistance against tumiiouir. This he called concomitant induced immunity The early experimental work on mammalian tuinours mostly in imiee and rats demonstrated clearly that tumours in animals were identical with tuimours in man in respect of mode of origin, age incidence, clinical course, mode of growth and infiltration of surrounding tissues, and formation of metastases. Transplantation could only be carried out within the species. There w-as strict specificity. The daughter tumours were derived entirely from the cells of the implanted graft. Tumoturs could only be propagated by means of the transplantation of living cells.
Until 1909 these constituted the most important facts concerning the knowledge of experimental tumouir and resistance to tumour. During the next decade, however, the work of Rouis and his associates on virus-induced tumours and the work of Yamagiwa and Ichikawa on chemically-induced tumours, was destined to change the course of investigations. The latter workers induced tumours in rats and mice by repeated application of tar to the skin. Tar tumours can be transplanted only within the species and only by means of the living cell. Kennaway and Cook in England, and Fieser in the United States, have made extensive investigations of the chemical aspect of this problem, the outstanding feature of which is the variety of chemical agents that will induce tumour, and the fact that once the tumouir is induced the chemical agent no longer operates in perpetuation of the growth. From the aspect of resistance, therefore, the chemically-induced tumours do not differ from mammalian tumours.
In 1910, however, Rous, Murphy, an(d Tytler, working in the Rockefeller Instituite, found, among fowls, a number of sarcomas which could be propagated by means of a cell-free filtrate. At first, most pathologists thought that these tumours were due to inflammation and were not true sarcomas, but as a result of fuirther investigation they are now generally considered to be true cancers. Rous sarcoma No. 1, as the most inmportant strain is now called, is one of the most universally used laboratorv tumours.
It was wNith this tumour that Gye did most of the work on which he based his virusspecific factor. It is caused by a virus by means of which it can be transmitted from fowl to fowl. It thus differs from the formerly known mammalian tumours which required the transfer of living cells for the formation of a new growth. Yet in every other way e.g. marked species specificity, malignant invasion of normal tisslues, and metastases-the Rous sarcoma is identical with mammalian turmours.
Rous found that certain growing tumours regressed and that the bird was subsequently resistant to tumour growth. He injected the serum of resistant birds into tumour-bearing birds, but found no alteration in the growth of the tumlouir in the treated animals.
Mottram found that when Rouis tuinours were made to regress by means of the application of radiation, some birds w-ere immune to subsequent tumour inoculation.
Resistance to Rous Chic.k,en Sarcoma. Since 1926, a study of Rous sarcoma has been made in our laboratory using pure-bred Barred-Rock fowl obtained from the Ontario Agricultural College. The birds used were fully-grown chickens from 6 to 12 months old. Younger birds were used during the spring months of certain years. The age of the bird is an important factor, because in young birds Rotis sarcoma develops more readily than in old ones and kills more rapidly. Gye used young chicks, and reported that in 6,000 birds he found only one in which a tumiour regressed.
In order to have a constant supply of tumour tissue for experimental purposes, transplantations into from three to six normal chickens were carried out every week. Transplants were made into the muscle of both breasts with a trocar of about 2 mm. diameter. When tissue was required for experiments or transplantation, the chicken with the most rapidly growing tumour was killed, and thus the birds with the more slowly growing tumours wrere allowed to survive.
In the six-year period 1928 to 1934, 1,768 chickens wNere transplanted. Of these 621 were killed to supply tumour tissue; of the remaining 1,147 birds, 1,140 diedI of tumouir and seven that is, one in 164 became resistant to Rous sarcoma. A resistant bird is one in which a well-established tumour regresses on adlditional transplantation a second small tutnour may develop, which also regresses. The bird does not develop tumours on subsequent transplantation with the cells of the tumour to wshich it is resistant, and it does not (lie of tumour.
DIuring the past ten years w-e have used approximately 6,000 fowNls for experimental work on Rous tumouir and of these 118, or approximately one bird in '50, has shown some degree of resistance. Of the 118 birds there w-ere 44 birds which receive(l more than five direct transplants and remained negative followsing regression of the first tutnouir. Some of this group were kept in the laboratory as long as five years, during wNhich time they received upw-ards of 40 transplants. Thirtv-eight of these birds have died and at autopsy showed no sign of tumour. Six are still alive and w ell.
In addition, there w-ere 15 birds which remnained negative following two or more transplanits. Four birds of this group are alive; the other 11 birds show-ed no sign of tumour at autopsv.
Thirteen birds remainedl negative to cell-free tumour extract on repeated occasionls but developed tumours and died following the inoculation of Rouis cells. A fowl may therefore be resistant to cell-free filtrate but not to transplanted cells. In 20 birdis a tumouir of large size regressed, but on subsequent transplantation the bird againi dleveloped a tumour and die(l. One bird, for example, had in all, five large tumours over a period of two years. Four of the tumours regressed but the bird died as the result of the fifth. Five birds lost their resistance to tumour and died bearing a large tumour. An example of this was a bird (No. 4172) which had received two injections of tumour extract, and 21 inoculations of Rous cells, between November 1, 1933, and March 10, 1936. Following the twenty-second transplantation of cells a large tumour developed which caused the death of the bird. The remaining 21 of the 118 birds may be classed as " partially resistant." They have died of tumour. Some of this group have had a tumour develop and regress following many transplantations. Some birds have had a very slow-growing tumour in one breast and bave been resistant to the injection of tumour extract or to the inoculation of cells into the other breast. Instances have been observed where a large tumour in one breast had almost disappeared when the direct transplant or an injection of tumour extract into the opposite breast caused a rapid growth of the original tumour. There is thus a very marked variation in the degree of resistance among fowls.
From the very earliest work on transplantable tumours it was observed that the size of the transplant had an important bearing on the result. Purdy has emphasized this point again in the growth of Fujinami tumours in adult ducks. It was thought, therefore, that a tumour might be produced in a resistant bird by the administration of a large dose of active tumour cells. On August 1, 1933, bird No. 373 was given 6 c.c. of finely divided tumour cells in the breast muscle. This dose was estimated to contain sufficient tumour-producing substance to kill 3,000 birds. The bird developed a tumour which in eight days measured 1 4 by 3-5 cm. Twro weeks later the mass had entirely absorbed and the breast was quite normal. Thus a highly resistant bird can overcome the growth activity of enormous nuimbers of active tumour cells.
Regression of Anin).al Ttnoours. The manner in which regression occurs in a
Rous sarcoma varies with the type of tumour. The slow-growing, firm, fibrous tumour regyresses slowly, becoming smaller and smaller, until it has entirely disappeared, leaving soft, normal muscle. A rapidly-growing, soft, cellular tumour usually develops a line of demarcation between itself and the muscle; it then begins to shrink in size the overlying skin, which is usually red, shining, and stretched, regains its normal appearance. The tumour may gradually separate from the muscle and form a cyst which usually persists for many months before it is absorbed.
Sometimes it would appear that the cells of a rapidly-growing tumouir simply die in mass. The dead tumour becomes a dry, black, desiccated mass which, like a foreign body, is ulcerated through the skin and extruded. As is frequently stated, a tumour-bearing animal does not die of the actual healthy growing tumour, even though the mass may be almost the size of the animal. Death is caused by infection of the tumour, ulceration, or the invasion of essential internal organs heart, lungs, or liver with secondary growth, or by the toxins absorbed from extensive necrosis of the tumour cells. When large amounts of waste products of breaking-down tumour are being absorbed, the bird loses weight, and is pale and inactive. One of the first signs of regression is often found in the appearance of the bird. The comb becomes red, the bird gains in weight and becomes active, even though the tumour is still quite large.
Woglom has investigated the histology of regressing tumours in the rat using the Flexner-Jobling tumour. He first found that if two transplants are inoculated at the same time, either both progress or both regress. He therefore transplanted tumour tissue into rats, in both flanks, and removed one of the transplants at varying intervals, leaving the other in the animal, for observation. In this manner he was able to obtain tumours at the period of beginning regression. On histological examination he found that the peripheral cells of the tumour, or in other words, the cells in most intimate contact with the host, were the first to degenerate. The death of the tumour was from without inward. This would seem to be the case in rapidly- Very early in the investigation (June 1930) it was found that the plasma of Rousresistant birds neutralized the cell-free active filtrate of a Rous tumour. The plasma of a resistant bird was mixed with tumour extract, incubated at 37 5°C. for one-half to three hours and injected into each of three birds. No tumours resulted. Normal bird plasma tested in the same manner had no such neutralizing effect. Over forty experiments of this nature have been carried out. Whereas in the early experiments 2 c.c. of resistant plasma were used to neutralize 1 c.c. of tumour extract, in later work as little as _1I6 of 1 c.c. or less, completely neutralized 1 c.c. of potent extract. This is probably due to the hyperimmunity developed in resistant birds as a result of repeated tumour-cell inoculation.
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Rous treated five tumour-bearing birds with a single transfuision of fromn 35 to 60 c.c. of blood from resistant birds, but the tumours grew quite as well as those of untransfused controls. We repeated this experiment on two occasions when we bad 15S resistant birds. Blood was drawn from these once a week and their mixed plasma used for treatment. Incubation tests showed that 0-1 c.c. of this mixed plasma completely neutralized 1 c.c. of potent tumour extract.
In the second experiment one normal bird was given 1 c.c. of tumour extract and eleven days later, when the tumour measured 2 by 2-2 cm., resistant plasma treatment was begun. The bird was given 15 c.c. twice daily during the first week and 10 c.c. daily during the second week. In this way 283 c.c. of resistant bird plasma was administered, but despite this large amount the tumour increased rapidly in size and the bird died in thirty days with a large breast tumour and metastases in the lungs.
From the fact that large amounts of highly immune plasma had no effect on the growth of a tumour, and from the experiments of Fischer, it would appear that the virus, being within the cancer cell, is not affected by the antibodies of the blood.
Fischer grew Rous cells in tissue culture and to the culture media he added the serum of a bird which had been resistant to five Rous transplants. He carried his tissue cultures through thirty generations over a period of two and a half months, at the end of which time the cells were inoculated into a bird and produced a tumour.
Sac Grafts in Rous-resistant Chickens.-When Rous cells are injected into a resistant bird the cells die and are absorbed. The question is: Do these cells die from lack of blood supply, or are they actually killed by the antibodies of the blood ? In order to throw some light on this question, fragments of Rous cells, of the size generally used for transplantation, were placed in sacs made from fresh hen peritoneum. In some cases the hen peritoneum was treated with silver salts and thoroughly washed. These sac grafts were placed in the breast muscle of resistant birds and removed at intervals up to ten days. On removal they were immediately grafted into the muscle of normal birds. Of 20 sac grafts which had remained in resistant birds for more than forty-eight hours, only one produced a tumour. Of the six sac grafts which were removed from resistant birds in forty-eight hours or less, only two produced tumours wheni placed in normal birds. From these experiments it would appear that the concentrated immune serum which bathed the cells in such a graft had a lethal effect on the tumour cells. The point as to whether or not the cell membrane can afford absolute protection to the virus against immune serum is an important one and requires further investigation.
.Neutralizing Effect of Rous-resistant Plasma on Rous Sarcoma Extract in Vivo. Since the administration of immune plasma to a bird had no effect if the tumour was well established, it was decided to give the plasma at the same time as the tumour inoculation. Tumour extract was mixed with immune bird plasma and injected iiimediately. It was found that one or two of the three birds so injected always developed a tumour. Hence it appeared that imnmune plasma required time for the neutralization of the virus.
When cell-free tutmouir extract was adminiistered intravenously through a fine needle and washed in with saline, no tumnour developed unless there was a foci of inflammation or vascular disturbance as, for example, in the ovary of a laying hen. This observation was used in order to ascertain whether or not the neutralization of tumour extract by immuniie plasma could be made to occur in vivo. Nine birds wvere each given 1 c.c. of a dilute soluitioni of turpentine (1: 40) in the right breast. The following day three of these birds were given intravenously 10 c.c. of a mixtlure of equal parts of immunie plasma and tutmiour extract that had been incubated for three hours at 37-53 (C. The next three birds were given intravenously 10 c.c. of a mixture of equal parts of normal bird plasma and tumour extract incubated three hours at 37 5' C. The last three birds were given intravenously 5 c.c. of resistant bird plasma and 5 c.c. of tulmour extract through the same needle from different syringes.
The nornial serumll control birds all died of breast tumours. The birds which received the non-inicubated, unmixed iminune plasma and tutnour extract all died of breast tumours, while Iio breast tumours developed in birds receiving the incubated resistant plasma and tumour extract mixture. One of these birds developed a tumour on the wing at the site of injection.
This experiment indicated that the neutralizing effect of the immune plasma occurred in the test tube during incubationi and required time for the inactivation to occur.
Rous-resistant Plasma as a Prophylaxis to Developnient of Rous Sarcowa.
Experiments were carried out to ascertain if fowls could be protected against tumiour by meeans of resistant bird plasma. Three birds received 30 c.c. of plasma during the week before receiving an injection of 1 c.c. of tumour extract. Each bird received three doses of 10 c.c. of the resistant plasma in breast muscle. None of the birds developed tumnours. A grouip of six birdls were treated w%ith 20 c.c. of resistant bird plasma for six days before receiving tumtour extract. Each bird received three doses intraperitoneally. Only one bird developed a tumour, and this killed it in forty-nine days. The remaining five birds received a second dose of tumour extract three weeks later and all died of tumour. It was found, however, that smaller doses of plasma did not protect the birds against tumour extract. When 10 c.c. of plasma were given 12 birds out of 15 developed tumour.
From these experiments it will be seen that it was necessary to give approximately 30 c.c. of resistant plasma in order to protect a bird against the injection of 1 c.c. of potent tumour extract. This is a relatively large amount; in a test tube this same amount of plasma would more than neutralize 300 c.c. of the same extract. therefore, it appeared that the plasma, when injected into the body, was diluted by the body-fluids and blood, and unless large quantities of serum were given, there was not sufficient concentration at the site of inoculation to bring about the neutralization and protection of the local celis.
Four birds were treated with immunie plasma for a week before tumour-cell transplantation. Each bird received 20 c.c. intraperitoneally, in three doses. All the birds developed tumours and died within twenty-eight days. Here again is seen the difference between extract and cell, resistant plasma being ineffective against the growth of cells.
All tissues of a resistant bird appear to be resistant both to cell-free filtrates and to Rous tumour cells. Two resistant birds were each given an intravenous injection of 3 c.c. of a very finely chopped suspension of Rous cells. The birds did not die, nor did they show any evidence of metastases. Control birds receiving 1-5 c.c. of the same suspension died in thirteen and sixteen days, respectively, with multiple tumours in internal organs, especially in the lungs.
Extracts were made from fresh tissues of two resistant bir(ds. It was foun(d that 6 250 extracts of liver neutralized tumouir extract as completely as resistant serulm; extracts of muscle and kidney w%ere less effective but showred some evidence of neutralizing effect one out of three birds developing a tumour. Resistance to Fujinami Tumour in Chickens. Since 1933 we have also had available for study the Fujinami tumour, a myxo-sarcoma which was originally discovered in a chicken but which can be propagated in both chickens and ducks.
In our experience the Fujinami tumour showed a much greater tendeney to regress, and thus to confer resistance, than did the Rous. Pure-bred Barred-Rock birds were uised as in the case of the Rous tumour. During the course of all experiments 180 birds were used. Of these 158 died of tumour or were killed in order to obtain Fujinami tumouir cells, while 22 fowls showed some degree of resistance: that is, one bird in eight, as compared with one bird in 51, in the case of Rous sarcoma. Twelve birds that were resistant to Fujinami tumouir-cells were inoculated with Rous extract or cells. Ten of these birds developed Rous tumours and died, while two became resistant to Rous tumour. Although Fujinami tumour has not been studied as extensively as Rous tumour, it wovuld appear that there is a similar variation in the (legree of immunity in the two tumours. Thus there are birds in which tumours do not develop following the injection of Fujinami tumour extract buit in which tumours develop following the injection of cells. Regression of one tumour does not always prevent the development of another tumour on subsequent transplantation.
Development of Fajinami Tumour and Dibenzanthracene Tumour in Rous-resistant
Chickens. In order to ascertain whether a bird which was resistant to Rous sarcoma ivould also be resistant to Fujinami tumour, two of our Rotis-resistant birds (Nos. 373 and 1038) were given an extract of dried Fujinami powder. Chicken No. 373 had been under observation for three years, during which time it remained negative to seventeen direct transplants of Rous sarcoma. Chicken No. 1038 had been under observation for over two years and had remained resistant to eleven Rous transplants. Both of these birds developed large tumours following the Fujinami inoculation and died with secondaries in the lungs, in thirty-five and forty-nine days respectively. Blood Nas obtained from the heart of bird No. 373 at autopsy and the plasma was found to completely neutralize Rous tuimour extract. Plasma of bird No. 1038 obtained within twenty-four hours of death, also neutralized Rous extract. This woould indicate that these birds remained resistant to Rous sarcoma although dying of Fujinami tumour.
It was also found that plasma of a Fujinami-resistant bird neutralized Fujinami cell-free extract but did not neutralize Rous extract. Conversely, plasma of a Rousresistant bird neutralized Rous cell-free filtrate but had no effect on Fujinami extract.
Twelve Rotis-resistant birds and 12 normal birds were each given three injections of 5) mgm. of 1.2.5.6-dibenzanthracene in lard into the breast muscle at fortnightly intervals. Four of the 12 resistant birds were given Rous transplants at intervals throughout the experiment and it was found that they remained negative to Rous. Eight of the 12 normal birds developed dibenzanthracene tumours, three remained negative and one died in four months from other causes. Six of the Rous-resistant birds developed tumours and six remained negative. At autopsy the tumours of the Rous-resistant birds were characteristic of dibenzanthracene. This was confirmed by histological section. Thus it may be concluded that a high degree of resistance to Rous does not protect a bird against the development ofa dibenzanthracene tumour.
The Role of the Monocytes in the Development of Tumours. Rous tumour is always the same, whether it is produced by the inoculation of cells or of cell-free filtrate. Hence it is important in the study of immunity to know the type of cell in which the virus grows. Carrell believed that the monocyte gave rise to Rouis tumour and reported that chicken monocytes, grown in tissue culture, could be transferred into tumour cells by the addition of Rous virus to the culture media.
Luidford w-as uinable to confirm this fin(ling but was able to produce Rous tuimour in vitro by growing chicken fibroblasts in culture media to which Rous cell-free extract had been added.
Of all the blood-cells, monocytes alone wander out into the alveoli of the normal lung; hence it was thought that if tumours arise from monocytes, tumour extract introduced into the lung should produce a tumour. Accordingly, by means of a soft rubber catheter, 1 c.c. of a potent tumour extract was introduced at the level of the bifurcation of the trachea. In four experiments 14 out of 15 birds died of massive lung tumours. Kaolin had been added to these extracts. In three experiments tumour extract without the addition of kaolin was administered, and four out of 12 birds developed lung tumours. Multiple tumour foci were seen scattered throughout the lung as early as six days after the introduction of the tumour extract to which kaolin had been added. These experiments indicate that the monocyte takes up the virus and carries it into the lung tissue. The histological appearance of the early miliary tumours of the lung would suggest that the monocyte was the cell that underwent malignant transformation.
Neutralizing Effect of Tumour Exudation. In the periodic examination of birds with growing tumours we sometimes encountered an exudation of fluid uinder the skin overlying the tumour. The tumour was always of the more slowlygrowing type. On a number of occasions the fluid was drawn off and it was found that it did not give rise to a tumour when injected into other birds, but, on the other hand, it had a neutralizing effect equivalent to that of resistant serum when added to tumour extract. Three of such tumour-bearing birds were studied extensively. Two of the birds died of tumour and it would appear that the tumour cells of these birds, although constantly exposed to immune serum, were not affected by it, because the virus was within the protecting cell. In the other bird the tumour regressed and the bird became resistant to six injections of tumour extract. It then received a direct transplant which resulted in a tumouir which regressed. Following this it was resistant to ten direct transplants and died without a tumour.
Attempts to Produce Resistance to Rous Sarcoma.-We have made many attempts to immunize fowl to Rous sarcoma. Following the principle of the toxin-antitoxin mixture used so extensively, we have given birds repeated injections of neutralized or partially neutralized serum-tumour extract mixtures. An example of one of the early experiments is as follows: Once a week, for five weeks, ten birds were each given 1 c.c. of tumour extract neutralized with resistant serum. Four weeks later each bird was given 1 c.c. of unneutralized tumour extract. Six of the 10 birds developed tumours and died. Of the other four, two became resistant and two partially resistant.
The procedure was modified and many experiments were carried out, but the difficulties could not be overcome. If too much serum was added there did not appear to be any immunity produced; if too little serum was added the injection resulted in a tumour which killed the bird. It was impossible to predict the potency of a tumour extract, consequently the amount of serum necessary to neutralize it could not be calculated.
Owing to the many failures to produce with constancy even minor degrees of resistance to Rous sarcoma, it was thought that the production of resistance might be connected with the tumour-cell itself. The object was to kill the tumour-cell by physiological means so that the hypothetical antigenic properties might remain. For this purpose it was decided to use ammonia, since that is a by-product of cell metabolism. The procedure was as follows: Tumour tissue was ground through strong cotton, which gave a fine suspension of cells. Ammonium chloride and ammonium carbonate solutions were made (2, 5, 10, 15, and 20 grm. per 100 c.c.) .
In order to obtain a neutral solution, one part of ammonium carbonate and nine parts of ammonium chloride were used. Tumour cells were added to ammonia Section of Therapeutics and Pharmacology 253 mixtures of varying percentages, shaken for four hours, and recovered by centrifugation. It was found that the cells thus treated, even when 20% ammonia was used, gave rise to a tumour when injected into normal birds. This wsas surprising, since it was found that Balogh mouse sarcoma cells were killed when treated with 10% ammonia solutions. Suspensions of Rous cells were treated with ammonia and then exposed to immune plasma. However, no resistant birds were produced by any of these procedures.
In 1925 Vallee, Curre and Rinjard produced immunity to foot-and-mouth disease by the injection of the virus killed by exposure to low concentrations of formaldehyde.
Since that time it has been found that formaldehyde removes the toxicity and kills other viruses without altering the specific antigen.
Mendel found that glyceric aldehyde, which has the same aldehyde group of molecules as formaldehyde, prevented aerobic glycolysis of tumour slices in the Warburg apparatuis. Glyceric aldehyde, being a three-carbon sugar, has the adde(d advantage that it can be administered intravenously or intraperitoneally. We atttempted to immunize birds to Rous tumour by injecting them with tumouir cells which had been treated with glyceric aldehyde. The tumour tissue was reduced to a fine pulp by grinding it through strong cotton. The cells were suspended in a 0-40% solution of glyceric aldehyde and shaken at interva,ls for three hours; they were recovered by centrifugation, suspended in normal saline. Six birds each received 2 c.c. of this suspension. Three developed tumours and died in the usual time.
Two others developed tumours which regressed, but on retransplantation they died of tumour. The other bird did not develop a tumour; it also remained negative following the injection of two active tumour extracts, but on receiving a transplant it (leveloped a tumour and died in twenty-five days.
Other experiments were carried out by giving birds repeated injections of Rous cells treated with glyceric aldehyde. 40/ glyceric aldehyde was uise(I for the first four or five treatments, and 0.400 for the later injections. It was found that the injection of cells treated in this way did not appear to promote the formation of antibodies against tumour. However, from the earlier experiments, when the cells were exposed to the dilute solutions of glyceric aldehyde, in some cases they produced a more slowly growing tumour from which the bird recovered. Birds with tumours were also treated with glyceric aldehyde but without effect. The results of the experiments with glyceric aldehyde were not sufficiently promising to warrant further work.
Re8istance to Mammalian Tumours in Mice. A study has also been made of resistance to mammalian tumours in mice. Tumour 63, C 180 and Balogh have been used, and it was found that spontaneous regression occurred with all these strains. During a two-year period 1,216 mice were transplanted with C 180. Of these 85 mice became resistant following the regression of the first tumour and died withouit a tumour, i.e. 1 in 14 mice became resistant. During a two-and-a-half-year period, 1,489 mice were transplanted with Balogh cells and 13 became resistant, i.e. 1 in 114 mice. This indicates that of all experimental mouse tumours the Balogh is possibly the most malignant and for this reason is comparable to the Rotis tuimour in chickens.
Many of the experiments which were carried out with chickens in an endeavouir to produce resistance were modified and repeated with mice, using Balogh tumourfor example, the injection of cells treated with ammonia and with glyceric aldehyde.
As was the case with the chickens, usually a small number of each group indicated that some degree of resistance had been produced, but for the most part the results were not satisfactory.
My colleague, Dr. Franks, is approaching the problem from an entirely different angle. He has sought to immunize mice against dibenzanthracene tumouirs by the repeated administration of (libenzanthracene which has been rend(lered antigenic by linking it with a protein. These experiments are in progress but it is too early to predict the results. Discussion All the work on experimental tumour requires a large number of animals and a great deal of time. It is essential that control animals be used in all experiments, but, even with this precaution, there is such a great variation in the individual bird or animal that results are often difficult to interpret. The most outstanding feature of the cancer problem is the specificity of the disease. Cancer is identical in fowl, in mice, and in man, yet the disease cannot, with few exceptions, be transmitted outside the species. Resistance to cancer is even more specific.
The work to date unfortunately does not appear to contribute much towtard a specific treatment for cancer. I believe, however, that a better understanding of the factors which produce immunity and resistance will ultimately lead to such a treatment.
The terms " immuinity " and " resistance " are used in association, althoulgh, as was pointed out at the beginning of this lecture, the two words refer to different conditions. The term "resistance" is used to indicate refractoriness to the grafting of cells; the term " immunity " to the condition under which an animal is able to combat, and possibly destroy, the intracellular agent which is known to be, for certain tumours, the proximate cause of the disease. The balance of evidence would lead most of us to conclude that the condition which I have called " resistance " is a laboratory phenomenon, unrelated to the realities of natural spontaneous cancer.
It may be simply an indication of a reaction between host and tumour cell where there is a difference in genetic constitution of host and cell. If this were the complete explanation of the phenomenon of resistance we could scarcely imagine that the forces which destroy a transplanted tumour could ever operate in natural cancer, in which the malignant cells have necessarily the same genetic constitution as the host. It w ill have been observed, however, that with regard to some of the experiments which I have described, there lurks in my mind the notion that the forces which effectively rid an animal of a spontaneous tumour may be a combination of anti-cellular and antiviral immune bodies. The spontaneous cure of natural cancer is very rare, but we have experimental tumours which can be propagated with cell-free filtrates andwhich are therefore the equivalent of spontaneous t'!mours, in that the tumours are composed of the host's own cells, and these tumouirs may, under certain circumstances, retrogress. As pointed out by Gye, the best example is the Fujinami tumour growing in ducks. When a relatively small dose of filtrate is injected into ducks, a tumouir forms, grows rapidly, and almost always disappears. The less perfect example is the Shope rabbit papilloma which occasionally regresses. When regression of such tuimours takes place the question arises whether the regression is brought about by the development of immune bodies which destroy the virus. Or is it a more complex process ? Kidd has investigated this problem. He has analysed by experimental methods the factors which determine the observed differences in the clinical progress of virus-induced papillomas and has shown that some are referable to the virus, some to the infected cells, and some to host influences. The interplay of these factors may determine either an unlimited growth of the tumour or i t . s retrogression. He attributes self-cure of this tumour to a generalized resistance of host origin, elicited by and directed against the virus-infected cells. The opinion inherent in this work is that antigenic differences between host and malignant tissues may be sufficiently great to stimulate curative antibodies adequate to ensure the disappearance of even spontaneous cancers, and it is along these lines that the greatest hope for cancer therapy exists.
